Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    tarsa
Show Display Options
RSS Create an RSS feed from your search for:
tarsa
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Oral Calcitonin Tablets;   Drug: Intranasal Calcitonin;   Drug: Placebo tablets and placebo intranasal spray
2 Completed
Has Results
A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
Condition: Osteopenia
Interventions: Drug: Oral calcitonin at dinnertime;   Drug: Oral placebo at dinnertime;   Drug: Oral calcitonin at bedtime;   Drug: Oral placebo at bedtime
3 Completed
Has Results
A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women
Condition: Osteoporosis
Interventions: Drug: Recombinant Salmon Calcitonin (rsCT);   Drug: Oral Tablet;   Drug: Nasal Spray
4 Completed
Has Results
A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women
Condition: Phase 1 Pharmacodynamic Study
Interventions: Drug: Oral rsCT tablet;   Drug: Oral Placebo Tablet;   Drug: Fortical (rsCT) nasal spray
5 Active, not recruiting Post Authorisation Safety Study (PASS) on Patients With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention:
6 Completed Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants
Conditions: Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal B vaccine;   Biological: Control;   Biological: Meningococcal B vaccine with antipyretic

Indicates status has not been verified in more than two years